Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

258 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Regulatory T cells in melanoma: the final hurdle towards effective immunotherapy?
Jacobs JF, Nierkens S, Figdor CG, de Vries IJ, Adema GJ. Jacobs JF, et al. Among authors: adema gj. Lancet Oncol. 2012 Jan;13(1):e32-42. doi: 10.1016/S1470-2045(11)70155-3. Lancet Oncol. 2012. PMID: 22225723 Review.
Identification of a novel peptide derived from the melanocyte-specific gp100 antigen as the dominant epitope recognized by an HLA-A2.1-restricted anti-melanoma CTL line.
Bakker AB, Schreurs MW, Tafazzul G, de Boer AJ, Kawakami Y, Adema GJ, Figdor CG. Bakker AB, et al. Among authors: adema gj. Int J Cancer. 1995 Jul 4;62(1):97-102. doi: 10.1002/ijc.2910620118. Int J Cancer. 1995. PMID: 7541395
Generation of antimelanoma cytotoxic T lymphocytes from healthy donors after presentation of melanoma-associated antigen-derived epitopes by dendritic cells in vitro.
Bakker AB, Marland G, de Boer AJ, Huijbens RJ, Danen EH, Adema GJ, Figdor CG. Bakker AB, et al. Among authors: adema gj. Cancer Res. 1995 Nov 15;55(22):5330-4. Cancer Res. 1995. PMID: 7585596
Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes.
Bakker AB, Schreurs MW, de Boer AJ, Kawakami Y, Rosenberg SA, Adema GJ, Figdor CG. Bakker AB, et al. Among authors: adema gj. J Exp Med. 1994 Mar 1;179(3):1005-9. doi: 10.1084/jem.179.3.1005. J Exp Med. 1994. PMID: 8113668 Free PMC article.
pMel17 is recognised by monoclonal antibodies NKI-beteb, HMB-45 and HMB-50 and by anti-melanoma CTL.
Adema GJ, Bakker AB, de Boer AJ, Hohenstein P, Figdor CG. Adema GJ, et al. Br J Cancer. 1996 May;73(9):1044-8. doi: 10.1038/bjc.1996.202. Br J Cancer. 1996. PMID: 8624261 Free PMC article.
Dendritic cells in immune response induction.
Marland G, Bakker AB, Adema GJ, Figdor CG. Marland G, et al. Among authors: adema gj. Stem Cells. 1996 Sep;14(5):501-7. doi: 10.1002/stem.140501. Stem Cells. 1996. PMID: 8888491 Review.
Analogues of CTL epitopes with improved MHC class-I binding capacity elicit anti-melanoma CTL recognizing the wild-type epitope.
Bakker AB, van der Burg SH, Huijbens RJ, Drijfhout JW, Melief CJ, Adema GJ, Figdor CG. Bakker AB, et al. Among authors: adema gj. Int J Cancer. 1997 Jan 27;70(3):302-9. doi: 10.1002/(sici)1097-0215(19970127)70:3<302::aid-ijc10>3.0.co;2-h. Int J Cancer. 1997. PMID: 9033632
Cloning, expression and tissue distribution of the murine homologue of the melanocyte lineage-specific antigen gp100.
Schreurs MW, de Boer AJ, Schmidt A, Figdor CG, Adema GJ. Schreurs MW, et al. Among authors: adema gj. Melanoma Res. 1997 Dec;7(6):463-70. doi: 10.1097/00008390-199712000-00004. Melanoma Res. 1997. PMID: 9464618
Genetic vaccination against the melanocyte lineage-specific antigen gp100 induces cytotoxic T lymphocyte-mediated tumor protection.
Schreurs MW, de Boer AJ, Figdor CG, Adema GJ. Schreurs MW, et al. Among authors: adema gj. Cancer Res. 1998 Jun 15;58(12):2509-14. Cancer Res. 1998. PMID: 9635569
Biodistribution and vaccine efficiency of murine dendritic cells are dependent on the route of administration.
Eggert AA, Schreurs MW, Boerman OC, Oyen WJ, de Boer AJ, Punt CJ, Figdor CG, Adema GJ. Eggert AA, et al. Among authors: adema gj. Cancer Res. 1999 Jul 15;59(14):3340-5. Cancer Res. 1999. PMID: 10416590
258 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback